Boston Scientific Corporation Share Price
Stocks
BSX
US1011371077
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:02 11/09/2026 BST
|
After hours 01:00:00 | |||
| 42.98 USD | -0.28% |
|
43.62 | +1.50% |
| 09-11 | Global markets live: Oracle, IBM, Adobe, OpenAI, Macy's… |  |
| 09-10 | Health Care Down, but Not by Much, on Defensive Bias - Health Care Roundup | DJ |
| Market Cap | 62.29B 53.67B 50.82B 46.06B 86.41B 5,951B 86.85B 604B 232B 3,027B 234B 229B 9,566B | P/E 2026 * |
16.2x | P/E 2027 * | 17x |
|---|---|---|---|---|---|
| Enterprise Value | 71B 61.18B 57.93B 52.51B 98.5B 6,783B 99B 688B 265B 3,451B 267B 261B 10,905B | EV / Sales 2026 * |
3.33x | EV / Sales 2027 * | 3.04x |
| Free-Float |
82.47% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| BSX | Delayed | |
CBOE
| BSX | Real-time | |
|
Tradegate
| BSX | Real-time | |
|
Xetra
| BSX | Delayed | |
|
Boerse Muenchen
| BSX | Real-time | |
|
Wiener Boerse
| BSXC | End-of-day quote | |
|
Borsa Italiana
| 1BSX | End-of-day quote | |
|
London S.E.
| 0HOY | Delayed | |
|
Deutsche Boerse AG
| BSX | Delayed | |
|
CBOE
| Real-time | ||
|
Mexican S.E.
| BSX * | End-of-day quote | |
|
Börse Stuttgart
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
Swiss Exchange
| BSX | Delayed | |
|
CBOE
| 0HOY | Real-time |
Last Transcript : Boston Scientific Corporation
| 1 day | +1.50% | ||
| 1 week | -10.08% | ||
| Current month | -11.01% | ||
| 1 month | -16.04% | ||
| 3 months | -8.88% | ||
| 6 months | -38.27% | ||
| Current year | -54.92% |
| 1 week | 42.78 |  | 47.45 |
| 1 month | 42.78 | | 52.99 |
| Current year | 42.2 | | 100.9 |
| 1 year | 42.2 | | 105.65 |
| 3 years | 42.2 | | 109.5 |
| 5 years | 34.98 | | 109.5 |
| 10 years | 19.67 | | 109.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CEO | Chief Executive Officer | 61 | 31/10/2011 |
Jonathan Monson
DFI | Director of Finance/CFO | 52 | 29/06/2025 |
Kenneth Stein
CTO | Chief Tech/Sci/R&D Officer | - | 31/08/2009 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Mahoney
CHM | Chairman | 61 | 02/05/2016 |
Edward Ludwig
BRD | Director/Board Member | 74 | 28/02/2014 |
Ellen Zane
BRD | Director/Board Member | 74 | 14/04/2016 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Director | 2,040 | 0.0001% | ||
| 11/08/26 | Other | Controller/Auditor | 2,930 | 0.0002% | ||
| 10/08/26 | Other | Chief Financial Officer | 9,908 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.28% | -10.08% | -58.81% | -21.22% | 62.29B | |
| +1.10% | -0.65% | +24.10% | +18.43% | 225B | |
| -0.19% | -3.62% | +2.55% | -20.00% | 141B | |
| +2.41% | +0.67% | -19.02% | +22.09% | 130B | |
| -2.77% | -6.15% | +8.15% | +12.69% | 48.63B | |
| -0.49% | -1.97% | -20.35% | -15.53% | 49.39B | |
| +2.66% | -2.61% | +15.94% | +29.91% | 41.42B | |
| +1.67% | -0.25% | +35.01% | +55.09% | 40.12B | |
| -0.60% | -4.41% | -20.52% | +44.06% | 31.23B | |
| +2.57% | -5.39% | +107.88% | +33.41% | 31.17B | |
| Average | +0.61% | -4.00% | +7.49% | +15.89% | 80.08B | |
| Weighted average by Cap. | +0.60% | -2.76% | +4.78% | +10.76% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 21.33B 18.38B 17.4B 15.77B 29.59B 2,038B 29.74B 207B 79.48B 1,037B 80.11B 78.36B 3,276B | 22.31B 19.22B 18.2B 16.49B 30.95B 2,131B 31.1B 216B 83.11B 1,084B 83.77B 81.94B 3,426B |
| Net income | 3.8B 3.27B 3.1B 2.81B 5.27B 363B 5.29B 36.78B 14.14B 185B 14.26B 13.94B 583B | 3.68B 3.17B 3B 2.72B 5.11B 352B 5.13B 35.66B 13.71B 179B 13.82B 13.52B 565B |
| Net Debt | 8.72B 7.51B 7.11B 6.45B 12.09B 833B 12.15B 84.46B 32.48B 424B 32.74B 32.02B 1,339B | 5.45B 4.7B 4.45B 4.03B 7.56B 521B 7.6B 52.82B 20.31B 265B 20.47B 20.03B 837B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/09/26 | US$42.98 | -0.28% | 26,986,789 |
| 10/09/26 | US$43.10 | -4.14% | 22,690,902 |
| 09/09/26 | US$44.96 | -0.04% | 17,979,923 |
| 08/09/26 | US$44.98 | -5.90% | 29,028,776 |
| 04/09/26 | US$47.80 | +1.81% | 15,504,234 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BSX Stock
Select your edition
All financial news and data tailored to specific country editions
